These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7835264)

  • 21. [Management of total placental retention with oxytocin injected into the umbilical vein].
    Sepúlveda WH
    Rev Chil Obstet Ginecol; 1991; 56(2):111-3. PubMed ID: 1844606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
    Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J
    Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
    Huber MG; Wildschut HI; Boer K; Kleiverda G; Hoek FJ
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1216-9. PubMed ID: 1709781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of retained placenta using intraumbilical oxytocin injection.
    Wingeier R; Griggs R
    J Nurse Midwifery; 1991; 36(4):240-4. PubMed ID: 1895173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraumbilical vein injection of oxytocin and the third stage of labor: randomized double-blind placebo trial.
    Ghulmiyyah LM; Wehbe SA; Saltzman SL; Ehleben C; Sibai BM
    Am J Perinatol; 2007 Jun; 24(6):347-52. PubMed ID: 17564955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equine retained placenta: technique for and tolerance to umbilical artery injections of collagenase.
    Haffner JC; Fecteau KA; Held JP; Eiler H
    Theriogenology; 1998 Mar; 49(4):711-6. PubMed ID: 10732079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental retention in a bonobo (Pan paniscus).
    Halbwax M; Mahamba CK; Ngalula AM; André C
    J Med Primatol; 2009 Jun; 38(3):171-4. PubMed ID: 19236561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of dairy cows at parturition with prostaglandin F2 alpha or oxytocin for prevention of retained fetal membranes.
    Stevens RD; Dinsmore RP
    J Am Vet Med Assoc; 1997 Nov; 211(10):1280-4. PubMed ID: 9373366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volume and timing are key to use of intraumbilical oxytocin for management of retained placenta.
    Golan A
    Am J Obstet Gynecol; 1990 Jun; 162(6):1628-9. PubMed ID: 2360597
    [No Abstract]   [Full Text] [Related]  

  • 30. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Grupo Argentino de Estudio de Placenta Retenida.
    Carroli G; Belizan JM; Grant A; Gonzalez L; Campodonico L; Bergel E
    Br J Obstet Gynaecol; 1998 Feb; 105(2):179-85. PubMed ID: 9501783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous nitroglycerin for controlled cord traction in the management of retained placenta.
    Visalyaputra S; Prechapanich J; Suwanvichai S; Yimyam S; Permpolprasert L; Suksopee P
    Int J Gynaecol Obstet; 2011 Feb; 112(2):103-6. PubMed ID: 21144515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous access: a comparison of two methods.
    Duffy BL; Lee JS
    Anaesth Intensive Care; 1983 May; 11(2):135-7. PubMed ID: 6869776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2000; (2):CD001337. PubMed ID: 10796259
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience using "Huber Plus" needles in our infusion center].
    Tazumi K; Kouji K; Matsumura N; Nabetani Y; Kondo M; Tomono K; Mizuki M
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):105-8. PubMed ID: 18195536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of umbilical vein oxytocin on blood loss and length of third stage of labour.
    Shrestha P; Babu CS
    Nepal Med Coll J; 2007 Sep; 9(3):176-8. PubMed ID: 18092435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraumbilical oxytocin for the retained placenta.
    Golan A
    Am J Obstet Gynecol; 1988 Nov; 159(5):1309-10. PubMed ID: 3189466
    [No Abstract]   [Full Text] [Related]  

  • 37. Obstetric performance of a patient with multiple uterine and cervical fibroids and expectant management of retained placenta.
    Begum MH; Mustafa MS
    Saudi Med J; 2002 Nov; 23(11):1405-7. PubMed ID: 12506306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Huber needle in situ inpatients under continuous infusion chemotherapy: results of a study, Phase II].
    Milani A; Vernizzi S; Passoni C; Sociale O; Macciola F; Grimaldi C; Comensoli M; Peruzzotti G; Lunghi L; Colleoni M
    Prof Inferm; 2000; 53(2):71-4. PubMed ID: 11272087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The retained placenta.
    Weeks AD
    Afr Health Sci; 2001 Aug; 1(1):36-41. PubMed ID: 12789132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of peripheral intravenous cannulas in premature infants: a controlled study.
    Batton DG; Maisels MJ; Appelbaum P
    Pediatrics; 1982 Sep; 70(3):487-90. PubMed ID: 7050878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.